Logo image of CGA

CHINA GREEN AGRICULTURE INC (CGA) Stock Fundamental Analysis

NYSE:CGA - New York Stock Exchange, Inc. - US16943W2044 - Common Stock - Currency: USD

1.98  +0.01 (+0.51%)

After market: 2 +0.02 (+1.01%)

Fundamental Rating

1

Taking everything into account, CGA scores 1 out of 10 in our fundamental rating. CGA was compared to 85 industry peers in the Chemicals industry. Both the profitability and financial health of CGA have multiple concerns. CGA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CGA has reported negative net income.
In the past year CGA has reported a negative cash flow from operations.
In the past 5 years CGA always reported negative net income.
In the past 5 years CGA always reported negative operating cash flow.
CGA Yearly Net Income VS EBIT VS OCF VS FCFCGA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -16.58%, CGA is doing worse than 87.06% of the companies in the same industry.
With a Return On Equity value of -27.63%, CGA is not doing good in the industry: 84.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -16.58%
ROE -27.63%
ROIC N/A
ROA(3y)-24.98%
ROA(5y)-31.96%
ROE(3y)-37.32%
ROE(5y)-45.57%
ROIC(3y)N/A
ROIC(5y)N/A
CGA Yearly ROA, ROE, ROICCGA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

With a Gross Margin value of 20.99%, CGA is not doing good in the industry: 61.18% of the companies in the same industry are doing better.
CGA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CGA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.39%
GM growth 5Y-1.28%
CGA Yearly Profit, Operating, Gross MarginsCGA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

3

2. Health

2.1 Basic Checks

CGA does not have a ROIC to compare to the WACC, probably because it is not profitable.
CGA has more shares outstanding than it did 1 year ago.
CGA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CGA is higher compared to a year ago.
CGA Yearly Shares OutstandingCGA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CGA Yearly Total Debt VS Total AssetsCGA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

CGA has an Altman-Z score of -0.29. This is a bad value and indicates that CGA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.29, CGA is doing worse than 83.53% of the companies in the same industry.
CGA has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
CGA's Debt to Equity ratio of 0.11 is amongst the best of the industry. CGA outperforms 84.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -0.29
ROIC/WACCN/A
WACC6.78%
CGA Yearly LT Debt VS Equity VS FCFCGA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.04 indicates that CGA has no problem at all paying its short term obligations.
With a Current ratio value of 2.04, CGA perfoms like the industry average, outperforming 45.88% of the companies in the same industry.
CGA has a Quick Ratio of 1.48. This is a normal value and indicates that CGA is financially healthy and should not expect problems in meeting its short term obligations.
CGA has a Quick ratio (1.48) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.48
CGA Yearly Current Assets VS Current LiabilitesCGA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CGA have decreased strongly by -83.20% in the last year.
The Revenue for CGA has decreased by -23.65% in the past year. This is quite bad
The Revenue for CGA have been decreasing by -20.10% on average. This is quite bad
EPS 1Y (TTM)-83.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.61%
Revenue 1Y (TTM)-23.65%
Revenue growth 3Y-19.14%
Revenue growth 5Y-20.1%
Sales Q2Q%-22.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CGA Yearly Revenue VS EstimatesCGA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CGA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CGA Price Earnings VS Forward Price EarningsCGA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGA Per share dataCGA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CGA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHINA GREEN AGRICULTURE INC

NYSE:CGA (11/25/2024, 8:04:00 PM)

After market: 2 +0.02 (+1.01%)

1.98

+0.01 (+0.51%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-18 2024-11-18
Earnings (Next)02-07 2025-02-07
Inst Owners0.14%
Inst Owner Change0%
Ins Owners84.23%
Ins Owner Change0%
Market Cap29.28M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB 0.33
EV/EBITDA N/A
EPS(TTM)-1.99
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS6.14
BVpS6.96
TBVpS6.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.58%
ROE -27.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.99%
FCFM N/A
ROA(3y)-24.98%
ROA(5y)-31.96%
ROE(3y)-37.32%
ROE(5y)-45.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.39%
GM growth 5Y-1.28%
F-Score2
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.35%
Cap/Sales 0.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.48
Altman-Z -0.29
F-Score2
WACC6.78%
ROIC/WACCN/A
Cap/Depr(3y)41.14%
Cap/Depr(5y)27.6%
Cap/Sales(3y)0.98%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.65%
Revenue growth 3Y-19.14%
Revenue growth 5Y-20.1%
Sales Q2Q%-22.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.75%
OCF growth 3YN/A
OCF growth 5YN/A